Pharmaceutical Security Production Act
Summary
Pharmaceutical Security Production Act This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain. The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products. The commission terminates four years after the bill is enacted.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2023
Committee Review
Floor Vote
President
Introduced Jun 30, 2023
Last action Jul 7, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Jul 7, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jun 30, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 30, 2023
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Ritchie Torres
DDemocratic
Co
Brian K. Fitzpatrick
RRepublican
Co
Marcus J. Molinaro
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 4449
Scope: US
Hi! I can help you understand HR 4449. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline